Richard A. Heyman

Companies

• Enliven Therapeutics, Inc.Board member Feb 27, 2023 to now¹
• PMV Pharmaceuticals, Inc.Board member Sep 24, 2020 to now²
• Oric Pharmaceuticals, Inc.Board member Apr 23, 2020 to now³
• RayzeBio, Inc.Board member Sep 14, 2023 to Feb 27, 2024⁴
• Metacrine, Inc.Board member Sep 16, 2020 to Sep 6, 2022⁵
• Gritstone bio, Inc.Board member Sep 27, 2018 to Jun 22, 2022⁶
• Proteostasis Therapeutics (United States)Board member Dec 28, 2020 to Jun 4, 2021⁷
• Tango Therapeutics (United States)Board member Sep 3, 2020 to Sep 3, 2020⁸
• VivoSim Labs, INC.Board member Aug 23, 2013 to Aug 24, 2015⁹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ETEnliven Therapeutics, Inc. ELVN149,218 shares¹⁰$5.7M at $38.33Feb 19, 2026
• OPOric Pharmaceuticals, Inc. ORIC244,972 shares¹¹$3.1M at $12.51Jul 24, 2026
• RRayzeBio, Inc.0 shares¹²Feb 26, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 24, 2026Sold 6,100 shares at $12.02 of Oric Pharmaceuticals, Inc.¹¹
• Jul 24, 2026Sold 7,000 shares at $12.02 of Oric Pharmaceuticals, Inc.¹¹
• Jul 24, 2026Exercised options 3,500 shares at $1.60 of Oric Pharmaceuticals, Inc.¹¹
• Jul 6, 2026Sold 300 shares at $12.00 of Oric Pharmaceuticals, Inc.¹³
• Feb 17, 2026Sold 1,230 shares at $26.18 of Enliven Therapeutics, Inc.¹⁰
• Jan 20, 2026Sold 718 shares at $26.96 of Enliven Therapeutics, Inc.¹⁴
• Jan 20, 2026Sold 512 shares at $26.46 of Enliven Therapeutics, Inc.¹⁴
• Jan 16, 2026Sold 3,200 shares at $12.00 of Oric Pharmaceuticals, Inc.¹⁵
• Jan 16, 2026Sold 3,500 shares at $12.00 of Oric Pharmaceuticals, Inc.¹⁵
• Jan 9, 2026Sold 4,285 shares at $25.00 of Enliven Therapeutics, Inc.¹⁶
• Jan 8, 2026Sold 8,015 shares at $25.04 of Enliven Therapeutics, Inc.¹⁶
• Jan 8, 2026Sold 1,620 shares at $25.00 of Enliven Therapeutics, Inc.¹⁶
• Oct 3, 2025Exercised options 1,447 shares at $3.75 of Oric Pharmaceuticals, Inc.¹⁷
• Oct 3, 2025Exercised options 31,353 shares at $1.60 of Oric Pharmaceuticals, Inc.¹⁷
• Oct 18, 2024Sold 753 shares at $30.00 of Enliven Therapeutics, Inc.¹⁸
• Oct 18, 2024Sold 817 shares at $30.00 of Enliven Therapeutics, Inc.¹⁸
• Oct 15, 2024Sold 1,270 shares at $27.67 of Enliven Therapeutics, Inc.¹⁹
• Oct 4, 2024Sold 2,825 shares at $27.51 of Enliven Therapeutics, Inc.²⁰
• Oct 1, 2024Sold 518 shares at $27.54 of Enliven Therapeutics, Inc.²¹
• Sep 16, 2024Sold 1,270 shares at $22.41 of Enliven Therapeutics, Inc.²²
• Aug 15, 2024Sold 620 shares at $23.70 of Enliven Therapeutics, Inc.²³
• Aug 15, 2024Sold 650 shares at $22.82 of Enliven Therapeutics, Inc.²³
• Jul 31, 2024Sold 649 shares at $27.50 of Enliven Therapeutics, Inc.²⁴
• Jul 31, 2024Sold 1,702 shares at $27.51 of Enliven Therapeutics, Inc.²⁴
• Jul 15, 2024Sold 1,270 shares at $24.80 of Enliven Therapeutics, Inc.²⁵